Letter to the Editor Regarding the Article "Use of Autologous Dendritic Cell Vaccine CaTeVac in Melanoma Patients: Final Results of the DENDRON-01 Study". Voprosy onkologii, v. 72, n. 1, p. OF-2542, 11 Mar.2026.